http://lifestyle.matomyseo.com/

Author: Alpha Tau Medical Ltd.

Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update

March 9, 2026
Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer

February 24, 2026
Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead

January 29, 2026